Cargando…
Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City
Autores principales: | Barbhaiya, Medha, Frey, Marianna B., Levine, Jonah, Vitone, Gregory, Lally, Lindsay, Lockshin, Michael D., Bykerk, Vivian, Feldman, Candace H., Mandl, Lisa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122542/ https://www.ncbi.nlm.nih.gov/pubmed/35596096 http://dx.doi.org/10.1007/s10067-022-06203-1 |
Ejemplares similares
-
Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022) -
Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
por: Barbhaiya, Medha, et al.
Publicado: (2021) -
When a Diagnosis Has No Name: Uncertainty and Opportunity
por: Lockshin, Michael D., et al.
Publicado: (2021) -
Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology
por: Stamm, Bessie, et al.
Publicado: (2022) -
SLE: reconciling heterogeneity
por: Lockshin, Michael D, et al.
Publicado: (2019)